Drs Chan and Greenough comment:
We agree that only large trial sizes will detect small differences between groups, but such differences may not be clinically relevant. In addition, there are very few treatments that have no associated side effects and large trials are likely to expose a greater number of infants to such problems. In our study use of nasal CPAP resulted in agitation of seven infants with acute respiratory distress and two with chronic respiratory distress and hyperoxia in a further two infants. 
